Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 25 studies | 31% ± 12% | |
| fibroblast | 13 studies | 28% ± 9% | |
| glutamatergic neuron | 11 studies | 45% ± 27% | |
| oligodendrocyte | 11 studies | 29% ± 10% | |
| microglial cell | 10 studies | 30% ± 10% | |
| oligodendrocyte precursor cell | 10 studies | 33% ± 14% | |
| astrocyte | 10 studies | 32% ± 14% | |
| GABAergic neuron | 9 studies | 44% ± 23% | |
| macrophage | 9 studies | 31% ± 13% | |
| adipocyte | 9 studies | 28% ± 7% | |
| pericyte | 8 studies | 26% ± 10% | |
| smooth muscle cell | 8 studies | 23% ± 5% | |
| neuron | 6 studies | 38% ± 15% | |
| interneuron | 6 studies | 46% ± 24% | |
| epithelial cell | 6 studies | 28% ± 10% | |
| endothelial cell of lymphatic vessel | 6 studies | 33% ± 11% | |
| dendritic cell | 5 studies | 22% ± 2% | |
| myeloid cell | 5 studies | 23% ± 5% | |
| type I pneumocyte | 5 studies | 23% ± 6% | |
| granule cell | 4 studies | 28% ± 7% | |
| retinal ganglion cell | 4 studies | 27% ± 7% | |
| amacrine cell | 4 studies | 20% ± 3% | |
| retina horizontal cell | 4 studies | 24% ± 4% | |
| capillary endothelial cell | 4 studies | 22% ± 6% | |
| cardiac muscle cell | 4 studies | 24% ± 3% | |
| endothelial cell of artery | 4 studies | 19% ± 1% | |
| mast cell | 4 studies | 20% ± 3% | |
| lymphocyte | 4 studies | 23% ± 9% | |
| endothelial cell of vascular tree | 4 studies | 32% ± 18% | |
| erythrocyte | 4 studies | 56% ± 15% | |
| basal cell | 4 studies | 26% ± 14% | |
| GABAergic interneuron | 3 studies | 26% ± 3% | |
| glial cell | 3 studies | 19% ± 5% | |
| plasma cell | 3 studies | 30% ± 4% | |
| mesothelial cell | 3 studies | 23% ± 4% | |
| mononuclear phagocyte | 3 studies | 19% ± 4% | |
| vein endothelial cell | 3 studies | 34% ± 19% | |
| ciliated cell | 3 studies | 25% ± 4% | |
| glycinergic amacrine cell | 3 studies | 19% ± 2% | |
| hepatocyte | 3 studies | 32% ± 23% | |
| leukocyte | 3 studies | 24% ± 4% | |
| T cell | 3 studies | 21% ± 1% | |
| alveolar macrophage | 3 studies | 30% ± 8% | |
| monocyte | 3 studies | 28% ± 3% | |
| type II pneumocyte | 3 studies | 20% ± 5% | |
| transit amplifying cell | 3 studies | 35% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 4160.21 | 459 / 459 | 100% | 39.59 | 1118 / 1118 |
| esophagus | 100% | 2838.13 | 1445 / 1445 | 100% | 37.04 | 183 / 183 |
| thymus | 100% | 5072.12 | 653 / 653 | 100% | 44.27 | 605 / 605 |
| lung | 100% | 3577.24 | 577 / 578 | 100% | 32.55 | 1155 / 1155 |
| uterus | 100% | 3694.42 | 170 / 170 | 100% | 30.34 | 457 / 459 |
| brain | 99% | 2594.39 | 2625 / 2642 | 100% | 29.30 | 705 / 705 |
| ovary | 100% | 2589.37 | 180 / 180 | 99% | 17.94 | 427 / 430 |
| bladder | 100% | 3171.71 | 21 / 21 | 99% | 29.00 | 500 / 504 |
| prostate | 100% | 2679.08 | 244 / 245 | 100% | 22.29 | 500 / 502 |
| liver | 100% | 1594.71 | 226 / 226 | 99% | 17.28 | 402 / 406 |
| kidney | 100% | 2035.88 | 89 / 89 | 99% | 25.84 | 890 / 901 |
| stomach | 100% | 2137.79 | 359 / 359 | 99% | 26.87 | 282 / 286 |
| skin | 100% | 4132.06 | 1808 / 1809 | 99% | 36.35 | 465 / 472 |
| intestine | 100% | 2891.92 | 966 / 966 | 98% | 25.13 | 518 / 527 |
| adrenal gland | 100% | 2915.29 | 258 / 258 | 98% | 27.53 | 226 / 230 |
| pancreas | 98% | 1320.69 | 323 / 328 | 99% | 25.98 | 176 / 178 |
| adipose | 100% | 4623.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3904.73 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 27.72 | 29 / 29 |
| muscle | 100% | 3000.39 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2992.29 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 27.40 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.42 | 1 / 1 |
| heart | 99% | 2445.19 | 851 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 87% | 2386.52 | 807 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 85% | 13.23 | 68 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0007091 | Biological process | metaphase/anaphase transition of mitotic cell cycle |
| GO_0031145 | Biological process | anaphase-promoting complex-dependent catabolic process |
| GO_0070936 | Biological process | protein K48-linked ubiquitination |
| GO_0070979 | Biological process | protein K11-linked ubiquitination |
| GO_0051301 | Biological process | cell division |
| GO_0051445 | Biological process | regulation of meiotic cell cycle |
| GO_0007346 | Biological process | regulation of mitotic cell cycle |
| GO_0005813 | Cellular component | centrosome |
| GO_0005680 | Cellular component | anaphase-promoting complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0072686 | Cellular component | mitotic spindle |
| GO_0005819 | Cellular component | spindle |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0019903 | Molecular function | protein phosphatase binding |
| Gene name | CDC27 |
| Protein name | Cell division cycle protein 27 homolog Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC) Cell division cycle 27 Cell division cycle protein 27 |
| Synonyms | ANAPC3 D17S978E D0S1430E hCG_1993274 |
| Description | FUNCTION: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. . |
| Accessions | P30260 E9PRZ6 I3L328 ENST00000570740.1 ENST00000573502.1 ENST00000575483.5 ENST00000531206.5 [P30260-2] I3L1K3 I3L3Y5 ENST00000527547.5 I3L2Z8 ENST00000532893.5 I3L225 ENST00000573550.5 ENST00000533415.5 G5EA36 ENST00000571643.5 F6QPS0 ENST00000574304.5 I0EZ72 I3L394 ENST00000526866.5 I0EZ68 I3L3G1 ENST00000066544.8 [P30260-1] ENST00000570818.5 K7EMA6 I3L3H6 ENST00000576484.1 |